Pharmacotherapy of Obesity

149,79 €
inkl. 7% MwSt. und
ggf. zzgl. Versand

<P>After three introductory chapters that deal with the general theme of obesity – now regarded as a chronic disease – this volume discusses the drugs sibutramine and orlistat, which are approved for long-term use in the US and in much of the rest of the world. The three final chapters discuss future drug targets, like the central nervous system and gut hormones, and how to influence energy expenditure and substrate utilization.</P>